Loading...
XSHG
600252
Market cap1.36bUSD
Dec 05, Last price  
3.00CNY
1D
0.67%
1Q
10.29%
Jan 2017
-34.50%
IPO
169.41%
Name

Guangxi Wuzhou Zhongheng Group Co.

Chart & Performance

D1W1MN
XSHG:600252 chart
P/E
P/S
4.22
EPS
Div Yield, %
0.33%
Shrs. gr., 5y
-0.33%
Rev. gr., 5y
-9.85%
Revenues
2.27b
-26.67%
324,016,775321,168,473285,783,099628,166,157712,395,8881,425,697,3441,150,551,2651,945,718,4533,996,697,6413,214,406,3891,343,085,1451,670,061,9922,047,709,2763,298,765,2833,814,056,0853,676,393,7023,161,843,6462,713,769,8383,096,542,0532,270,823,188
Net income
-377m
L
019,663,50236,578,76047,007,169125,709,148398,574,986374,929,597683,921,037742,515,8781,594,536,436520,158,884489,356,682604,914,988613,351,971744,951,596236,081,657173,166,28912,389,67484,308,789-376,979,146
CFO
477m
-1.38%
56,136,744199,414,43140,754,22259,467,3750191,734,9910906,427,707945,099,660569,946,797291,525,5051,495,621,750893,214,443853,399,912654,312,676656,615,88400484,100,303477,427,055
Dividend
Jun 24, 20240.01 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers pills, capsules, and injections and tablets for cardiovascular and cerebrovascular diseases, bruises, gynecological diseases, and respiratory diseases. It also produces health food products under the DOUBLE MONEY brand, as well as health-care functional beverages, smokable turtle pastes, jelly-type turtle paste, etc. The company is based in Wuzhou, China.
IPO date
Nov 30, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT